Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer
The aim of the study was to examine the effect of a new tripeptide, Leu-Ile-Lys, on an experimental indometacin-induced gastric ulcer in rats. Materials and Methods: The experiment was performed with 24 male Wistar rats (average weight of 150 g). Rats were randomly divided into 3 groups: Group 1(n...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
International Medical Research and Development Corporation
2018-12-01
|
Series: | International Journal of Biomedicine |
Subjects: | |
Online Access: | http://ijbm.org/articles/IJBM_8(4)_OA_17.pdf |
_version_ | 1819200203943575552 |
---|---|
author | Aleksandr Yu. Zharikov Samira E. Lorents Igor P. Bobrov Olesya N. Mazko Olesya G. Makarova |
author_facet | Aleksandr Yu. Zharikov Samira E. Lorents Igor P. Bobrov Olesya N. Mazko Olesya G. Makarova |
author_sort | Aleksandr Yu. Zharikov |
collection | DOAJ |
description | The aim of the study was to examine the effect of a new tripeptide, Leu-Ile-Lys, on an experimental indometacin-induced gastric ulcer in rats.
Materials and Methods: The experiment was performed with 24 male Wistar rats (average weight of 150 g). Rats were randomly divided into 3 groups: Group 1(n=8) – the ulcer control group (IIGU), Group 2 (n=8) – the experimental group (IIGU+pre-treating with the tripeptide Leu-Ile-Lys), and Group 3 (n=8) – the comparison group (IIGU+pre-treating with omeprazole). The model of IIGU in rats was performed by a single intragastric administration of indomethacin (60mg/kg in 1ml of physiological saline). In Group 1, indomethacin caused the appearance of severe injuries of the mucosa with the presence of extensive edema and leukocyte infiltration in the submucosal layer. In animals of Group 2, which were pre-treated with the tripeptide Leu-Ile-Lys, macroscopically gastric mucosa also looked smooth and atrophic changes were not found. Destructive changes were not severe; they appeared only in the form of small spot erosions. The number of spot erosions was 2.6 times less than in Group 1. The average erosion depth was 6.8 times less than in Group 1, and 2.0 times less than in Group 3.
Conclusion: Results of this study demonstrated the high, comparable to the action of omeprazole, gastroprotective activity of the new tripeptide Leu-Ile-Lys. |
first_indexed | 2024-12-23T03:28:30Z |
format | Article |
id | doaj.art-18318d2be90b4cb78f7f6fdfe8aeb393 |
institution | Directory Open Access Journal |
issn | 2158-0510 2158-0529 |
language | English |
last_indexed | 2024-12-23T03:28:30Z |
publishDate | 2018-12-01 |
publisher | International Medical Research and Development Corporation |
record_format | Article |
series | International Journal of Biomedicine |
spelling | doaj.art-18318d2be90b4cb78f7f6fdfe8aeb3932022-12-21T18:01:46ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292018-12-018435135410.21103/Article8(4)_OA17Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric UlcerAleksandr Yu. Zharikov0Samira E. Lorents1Igor P. Bobrov2Olesya N. Mazko3Olesya G. Makarova4Altai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationThe aim of the study was to examine the effect of a new tripeptide, Leu-Ile-Lys, on an experimental indometacin-induced gastric ulcer in rats. Materials and Methods: The experiment was performed with 24 male Wistar rats (average weight of 150 g). Rats were randomly divided into 3 groups: Group 1(n=8) – the ulcer control group (IIGU), Group 2 (n=8) – the experimental group (IIGU+pre-treating with the tripeptide Leu-Ile-Lys), and Group 3 (n=8) – the comparison group (IIGU+pre-treating with omeprazole). The model of IIGU in rats was performed by a single intragastric administration of indomethacin (60mg/kg in 1ml of physiological saline). In Group 1, indomethacin caused the appearance of severe injuries of the mucosa with the presence of extensive edema and leukocyte infiltration in the submucosal layer. In animals of Group 2, which were pre-treated with the tripeptide Leu-Ile-Lys, macroscopically gastric mucosa also looked smooth and atrophic changes were not found. Destructive changes were not severe; they appeared only in the form of small spot erosions. The number of spot erosions was 2.6 times less than in Group 1. The average erosion depth was 6.8 times less than in Group 1, and 2.0 times less than in Group 3. Conclusion: Results of this study demonstrated the high, comparable to the action of omeprazole, gastroprotective activity of the new tripeptide Leu-Ile-Lys.http://ijbm.org/articles/IJBM_8(4)_OA_17.pdfpeptic ulcerIndometacineoligopeptidesgastroprotective activity |
spellingShingle | Aleksandr Yu. Zharikov Samira E. Lorents Igor P. Bobrov Olesya N. Mazko Olesya G. Makarova Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer International Journal of Biomedicine peptic ulcer Indometacine oligopeptides gastroprotective activity |
title | Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer |
title_full | Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer |
title_fullStr | Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer |
title_full_unstemmed | Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer |
title_short | Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer |
title_sort | pharmacologically active tripeptide leu ile lys in indomethacin induced gastric ulcer |
topic | peptic ulcer Indometacine oligopeptides gastroprotective activity |
url | http://ijbm.org/articles/IJBM_8(4)_OA_17.pdf |
work_keys_str_mv | AT aleksandryuzharikov pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer AT samiraelorents pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer AT igorpbobrov pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer AT olesyanmazko pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer AT olesyagmakarova pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer |